Daytime sleepiness is one of the most common symptoms encountered in sleep medicine, yet recent population-level data suggest that its prevalence and functional impact may be substantially underestimated1. Survey data indicate that approximately 70% of U.S. adults report struggling with sleepiness daily, suggesting that impaired daytime alertness extends far beyond patients with diagnosed sleep disorders2. These findings elevate sleepiness from a nonspecific complaint to a widespread clinical and public health concern, with implications for emotional regulation, cognitive performance, occupational functioning, and safety.
Complementing these prevalence estimates, the American Academy of Sleep Medicine (AASM) Sleep Prioritization Survey2 provides important insight into the domains of daily life most affected by sleepiness. In a nationally representative sample of more than 2,000 adults, respondents most frequently reported adverse effects on mood (60%), stress or anxiety levels (53%), and work productivity (42%), with additional impacts noted on physical health, exercise routines, relationships, and driving safety. For clinicians, these findings emphasize that sleepiness is not merely a subjective sensation of tiredness, but a marker of broad functional impairment.
From a biologic standpoint, daytime sleepiness reflects disruption across multiple interacting systems that regulate sleep-wake stability3. Normal alertness depends on the coordinated interaction of homeostatic sleep pressure, circadian timing, and ascending arousal systems within the central nervous system. When these systems fall out of balance, the ability to sustain wakefulness is compromised.
Homeostatic sleep pressure accumulates with prolonged wakefulness and is mediated in part by adenosinergic signaling within the brain. Inadequate sleep duration or poor sleep quality leads to incomplete dissipation of this pressure, resulting in persistent sleepiness during waking hours. Circadian misalignment further compounds this effect by weakening wake-promoting signals from the suprachiasmatic nucleus, particularly when sleep timing is inconsistent or misaligned with environmental light-dark cycles4.
At the same time, integrity of ascending arousal networks is critical for maintaining alertness. These systems involve coordinated activity across orexinergic neurons in the hypothalamus, monoaminergic pathways (including norepinephrine, dopamine, serotonin, and histamine), and cholinergic projections from the basal forebrain and brainstem. Dysfunction within these pathways, whether primary, as in central hypersomnolence disorders, or secondary to sleep fragmentation, reduces the brain’s capacity to sustain stable wakefulness despite adequate sleep opportunity4.
Many common sleep disorders converge on these shared physiologic mechanisms. Obstructive sleep apnea disrupts sleep continuity and architecture through recurrent arousals, leading to persistent elevation of homeostatic sleep pressure despite normal or extended time in bed5. Insomnia, particularly when associated with short sleep duration, produces a paradoxical state of chronic sleep deprivation alongside physiologic hyperarousal. Circadian rhythm sleep–wake disorders create temporal misalignment between endogenous alerting signals and socially required wake times, while narcolepsy and idiopathic hypersomnia directly impair wake-promoting neurochemical systems3.
Across conditions, the downstream consequences are similar: impaired vigilance, slowed reaction time, reduced executive functioning, and increased emotional reactivity. These neurobehavioral effects provide a mechanistic explanation for the survey findings showing widespread impacts of sleepiness on mood, stress tolerance, productivity, and interpersonal functioning. Notably, adults aged 25 to 44 years were the most likely to report relationship disruption, suggesting that sleepiness may be particularly destabilizing during life stages marked by high cognitive, occupational, and family demands.
For sleep medicine clinicians, these data reinforce the need for comprehensive assessment of daytime functioning in patients presenting with sleep-related concerns. Evaluation should extend beyond nocturnal symptoms to include inquiry into emotional regulation, cognitive efficiency, work performance, interpersonal strain, and daily safety risks. While standardized instruments such as the Epworth Sleepiness Scale remain useful, they may not fully capture the multidimensional impairments revealed by population-level survey data6.
Distinguishing sleepiness from fatigue, burnout, or depressive symptoms remains essential, as each may reflect different underlying mechanisms and require different therapeutic approaches. However, the frequent overlap among these presentations underscores the importance of a mechanistically informed evaluation that considers sleep duration, sleep quality, circadian alignment, and arousal system integrity.
Safety considerations warrant particular attention. A meaningful proportion of adults report that sleepiness affects driving safety. This echoes extensive epidemiologic evidence linking impaired alertness to increased risk of motor vehicle collisions, workplace accidents, and medical errors8. From a physiologic perspective, elevated sleep pressure and impaired arousal signaling predict microsleeps, attentional lapses, and slowed response times. Clinicians should routinely assess drowsy driving risk and counsel patients accordingly, particularly those with untreated sleep apnea, shift work schedules, or safety-sensitive occupations.
Emerging survey data indicate that daytime sleepiness affects the majority of U.S. adults and disrupts multiple domains of daily functioning. When interpreted through a physiologic lens, these findings align closely with established models of sleep–wake regulation and the known neurobehavioral effects of insufficient or disrupted sleep. For sleep medicine clinicians, this convergence underscores the importance of early identification, comprehensive functional assessment, and targeted intervention. Addressing sleepiness effectively has the potential to improve not only sleep-related outcomes, but also mood regulation, cognitive performance, productivity, and public safety.
1. Slater, Gemma, and Joerg Steier. “Excessive daytime sleepiness in sleep disorders.” Journal of thoracic disease vol. 4,6 (2012): 608-16. doi:10.3978/j.issn.2072-1439.2012.10.07
2. American Academy of Sleep Medicine (AASM), news release, Nov. 17, 2025
3. Steele, Tyler A et al. “Circadian Rhythm Sleep-Wake Disorders: a Contemporary Review of Neurobiology, Treatment, and Dysregulation in Neurodegenerative Disease.” Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics vol. 18,1 (2021): 53-74. doi:10.1007/s13311-021-01031-8
4. Schwartz, Jonathan R L, and Thomas Roth. “Neurophysiology of sleep and wakefulness: basic science and clinical implications.” Current neuropharmacology vol. 6,4 (2008): 367-78. doi:10.2174/157015908787386050
5. Baron, Kelly Glazer, and Kathryn J Reid. “Circadian misalignment and health.” International review of psychiatry (Abingdon, England) vol. 26,2 (2014): 139-54. doi:10.3109/09540261.2014.911149
6. Lv, Renjun, et al. "Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome." Signal transduction and targeted therapy 8.1 (2023): 218.
7. Gonçalves, Maria Teresa, et al. "Epworth sleepiness scale: A meta-analytic study on the internal consistency." Sleep medicine 109 (2023): 261-269.
8. Ward, Kim L et al. “Excessive daytime sleepiness increases the risk of motor vehicle crash in obstructive sleep apnea.” Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine vol. 9,10 1013-21. 15 Oct. 2013, doi:10.5664/jcsm.3072